Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitussystematic review and meta-analysis of cardiovascular outcomes trials
Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G
Adems, existen variaciones genticas que pueden afectar la produccin de GLP-1 o la sensibilidad de sus receptores, lo que podra influir en el riesgo individual de desarrollar trastornos metablicos
Comparing fat dissolvers to peptide-based fat loss For readers who arrived here searching for peptide-related fat loss information, understanding how injectable fat dissolvers compare to peptide-based approaches provides valuable context
69 LYSINE AND HEART HEALTH Ketones are the primary energy source for the heart